Showing results (91-100 of 114) with videos related to
Sort By:
Pageof 12
Journal of Crohn'S & Colitis|August 12, 2025
Results of the 9th Scientific Workshop of the European Crohn's and Colitis Organisation (ECCO): Artificial Intelligence in Endoscopy, Radiology and Histology in IBD DiagnosticsAart Mookhoek, Pieter Sinonque, Mariangela Allocca, et al.Journal of Crohn'S & Colitis|August 12, 2025
Results of the 9th Scientific Workshop of the European Crohn's and Colitis Organisation (ECCO): Artificial Intelligence in IBD: Regulatory and Methodological ConsiderationsNurulamin M Noor, Marco Daperno, Jan de Laffolie, et al.Journal of Crohn'S & Colitis|August 12, 2025
Results of the Ninth Scientific Workshop of the European Crohn's and Colitis Organisation (ECCO): Artificial intelligence in IBD surgery: opportunities and limitationsAlaa El-Hussuna, Gianluca Pellino, Alessandra Soriano, et al.Advances in Therapy|March 9, 2018
Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory DiseaseFernando Rizzello, Ignazio Olivieri, Alessandro Armuzzi, et al.Journal of Crohn'S & Colitis|September 24, 2016
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical ManagementFernando Gomollón, Axel Dignass, Vito Annese, et al.Journal of Crohn'S & Colitis|August 12, 2025
Results of the 9th Scientific Workshop of the European Crohn's and Colitis Organisation (ECCO): Artificial Intelligence in medical management and precision medicineUri Kopylov, Bram Verstockt, Urko M Marigorta, et al.Frontiers in Medicine|April 28, 2023
Personalize, participate, predict, and prevent: 4Ps in inflammatory bowel diseaseMarco Vincenzo Lenti, Maria Lia Scribano, Livia Biancone, et al.Alimentary Pharmacology & Therapeutics|October 25, 2021
Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD studyCristina Bezzio, Alessandro Armuzzi, Federica Furfaro, et al.Alimentary Pharmacology & Therapeutics|July 25, 2022
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG-IBD LIVE studyDaniela Pugliese, Giuseppe Privitera, Federica Crispino, et al.Gastroenterology|September 15, 2007
Neuropeptide s receptor 1 gene polymorphism is associated with susceptibility to inflammatory bowel diseaseMauro D'Amato, Sara Bruce, Francesca Bresso, et al.Pageof 12